Clinical Trials Logo
  1. Home
  2. Allergic Rhinitis
  3. NCT03112252
  4. Details
NCT03112252 Clinical Trial

App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season

Allergic Rhinitis Clinical Trial

Official title:
App-basierte Patientenbefragung Von Allergiepatienten Unter Medikation in Der Pollenflug-Saison Zur Bestimmung Der Auswirkung Einer Allergischen Rhinitis Auf Die Lebensqualität

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03112252
Other study ID # IITMACVIA2017D
Secondary ID
Status Completed
Phase N/A
First received March 30, 2017
Last updated October 24, 2017
Start date April 19, 2017
Est. completion date August 31, 2017

Study information
Verified date October 2017
Source University Hospital of Cologne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

App-based study of allergy patients under medication in the pollen season to determine the effect of allergic rhinitis on the quality of life.

Description:

The project aims to determine the effects of rhinitis on everyday life and thereby identify the affected pathways, irrespective of age, gender or gender socioeconomic status to lead a healthy and active life.

Recruitment information / eligibility
Status Completed
Enrollment 173
Est. completion date August 31, 2017
Est. primary completion date August 31, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility inclusion criteria patients with allergic rhinitis

exclusion criteria none

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no specifications. Depending on the patients
patients with allergic rhinitis

Locations
Country Name City State
Germany Institute of Medical Statistics, Informatics and Epidemiology Cologne NRW

Sponsors (1)
Lead Sponsor Collaborator
University Hospital of Cologne

Country where clinical trial is conducted

Germany, 

Outcome
Type Measure Description Time frame Safety issue
Primary allergic symptoms of patients allergic symptoms of patients during the pollen season one month
See also
  Status Clinical Trial Phase
Recruiting NCT05080322 - Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis Phase 4
Recruiting NCT06028490 - A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. Phase 2
Completed NCT04388358 - Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation N/A
Recruiting NCT04202263 - Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Phase 2
Completed NCT04078009 - Standardising Nasal Allergen Challenge in Adult With Hay Fever N/A
Completed NCT03644680 - Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study N/A
Completed NCT04541004 - Adolescent Mite Allergy Safety Evaluation Phase 3
Recruiting NCT05378594 - HDM and Silver Birch NAC Standardisation N/A
Not yet recruiting NCT05684380 - Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) Phase 3
Completed NCT02910401 - Clinical Response to Rhinovirus Challenge Phase 2
Not yet recruiting NCT01014325 - Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy Phase 3
Completed NCT02943720 - ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen Phase 2
Completed NCT02556801 - Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy Phase 2
Completed NCT02352168 - Airway Inflammation in Children With Allergic Rhinitis and Intervention N/A
Not yet recruiting NCT02233426 - Effect of Hypertonic Solutions on Allergic Rhinitis Patients N/A
Completed NCT01946035 - Alpha-Blockers in Allergic Rhinitis (MAN 01) Phase 4
Completed NCT01918956 - PURETHAL Birch RUSH Study Phase 4
Completed NCT01682070 - SUBLIVAC FIX Phleum Pratense DT/DRF Phase 2
Recruiting NCT01454492 - The Relationship Between Allergic Rhinitis and Geographic Tongue N/A
Completed NCT01438463 - PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis Phase 2